Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells

FASEB Journal

Volumn 22, Issue 8, 2008, Pages 2639-2651

  Oyesanya, Regina A ^a   Lee, Zendra P ^a   Wu, Jinhua ^a   Chen, Jing ^a   Song, Yuanda ^a   Mukherjee, Abir ^a   Dent, Paul ^a   Kordula, Tomasz ^a   Zhou, Huiping ^a   Fang, Xianjun ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

C EBP; GPCR; HuR; Receptor tyrosine kinase

Indexed keywords

BINDING PROTEIN; CYCLOOXYGENASE 2; ENHANCER BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; HUR PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 1; LYSOPHOSPHATIDIC ACID RECEPTOR 2; LYSOPHOSPHATIDIC ACID RECEPTOR 5; PROSTAGLANDIN; PROSTAGLANDIN E2; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; FEMALE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA STABILITY;

ANTIGENS, SURFACE; ARACHIDONIC ACID; BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DINOPROSTONE; DNA PRIMERS; FEMALE; HUMANS; LYSOPHOSPHOLIPIDS; MUTAGENESIS, SITE-DIRECTED; OVARIAN NEOPLASMS; PHOSPHORYLATION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, LYSOPHOSPHATIDIC ACID; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SEQUENCE DELETION; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS);

EID: 48749127821     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-101428     Document Type: Article

References (62)

1. Moolenaar, W. H. (2000) Development of our current understanding of bioactive lysophospholipids. Ann. N. Y. Acad. Sci. 905, 1-10
2. Eichholtz, T., Jalink, K., Fahrenfort, I., and Moolenaar. W. H. (1993) The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291, 677-680
3. Hecht, J. H., Weiner, J. A., Post, S. R., and Chun, J. (1996) Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 135, 1071-1083
4. An, S., Bleu, T., Hallmark, O. G., and Goetzl, E. J. (1998) Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J. Biol. Chem. 273, 7906-7910
5. Bandoh, K., Aoki, J., Hosono, H., Kobayashi, S., Kobayashi, T., Murakami-Murofushi, K., Tsujimoto, M., Arai, H., and Inoue, K. (1999) Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J. Biol. Chem. 274, 27776-27785
6. Noguchi, K., Ishii, S., and Shimizu, T. (2003) Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J. Biol. Chem. 278, 25600-25606
7. Lee, C. W., Rivera, R., Gardell, S., Dubin, A. E., and Chun. J. (2006) GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. J. Biol. Chem. 281, 23589-23597
8. McIntyre, T. M., Pontsler, A. V., Silva, A. R., St. Hilaire, A., Xu, Y., Hinshaw, J. C., Zimmerman, G. A., Hama, K., Aoki, J., Arai, H., and Prestwich, G. D. (2003) Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc. Natl. Acad. Sci. U. S. A. 100, 131-136
9. van Corven, E. J., Groenink, A., Jalink, K., Eichholtz, T., and Moolenaar, W. H. (1989) Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell 59, 45-54
10. Van der Bend, R. L., de Widt, J., van Corven, E. J., Moolenaar, W. H., and van Blitterswijk, W. J. (1992) The biologically active phospholipid, lysophosphatidic acid, induces phosphatidylcholine breakdown in fibroblasts via activation of phospholipase D. Comparison with the response to endothelin. Biochem. J. 285, 235-240
11. Howe, L. R., and Marshall, C. J. (1993) Lysophosphatidic acid stimulates mitogen-activated protein kinase activation via a G-protein-coupled pathway requiring p21ras and p74raf-1. J. Biol. Chem. 268, 20717-20720
12. Moolenaar, W. H., Kranenburg, O., Postma, F. R., and Zondag, G. C. (1997) Lysophosphatidic acid: G-protein signalling and cellular responses. Curr. Opin. Cell Biol. 9, 168-173
13. Mills, G. B., and Moolenaar, W. H. (2003) The emerging role of lysophosphatidic acid in Cancer Nature Rev. Cancer 3, 582-591
14. Fang, X., Schummer, M., Mao, M., Yu, S., Tabassam, F. H., Swaby, R., Hasegawa, Y., Tanyi, J. L., LaPushin, R., Eder, A., Jaffe, R., Erickson, J., and Mills, G. B. (2002) Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim. Biophys. Acta 1582, 257-264
15. Fang, X., Yu, S., Bast, R. C., Liu, S., Xu, H. J., Hu, S. X., LaPushin, R., Claret, F. X., Aggarwal, B. B., Lu, Y., and Mills, G. B. (2004) Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells. J. Biol. Chem. 279, 9653-9661
16. Sivashanmugam, P., Tang, L., and Daaka, Y. (2004) Interleukin 6 mediates the lysophosphatidic acid-regulated cross-talk between stromal and epithelial prostate cancer cells. J. Biol. Chem. 279, 21154-21159
17. Lee, Z., Swaby, R. F., Liang, Y., Yu, S., Liu, S., Lu, K. H., Bast, R. C., and Mills G. B., and Fang, X. (2006) Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer. Cancer Res. 66, 2740-2748
18. Hu, Y. L., Tee, M. K., Goetzl, E. J., Auersperg, N., Mills, G. B., Ferrara, N., and Jaffe. R. B. (2001) Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J. Natl. Cancer Inst. 93, 762-768
19. Pustilnik, T. B., Estrella, V., Wiener, J. R., Mao, M., Eder, A., Watt, M. A., Bast, R. C., and Mills, G. B. (1999) Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. Clin. Cancer Res. 5, 3704-3710
20. Symowicz, J., Adley, B. P., Woo, M. M., Auersperg, N., Hudson, L. G., and Stack, M. S. (2005) Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells. Cancer Res. 65, 2234-2242
21. Muehlich, S., Schneider, N., Hinkmann, F., Garlichs, C. D., and Goppelt-Struebe, M. (2004) Induction of connective tissue growth factor (CTGF) in human endothelial cells by lysophosphatidic acid, sphingosine-1-phosphate, and platelets. Atherosclerosis 175, 261-268
22. Liao, Z., Mason, K. A., and Milas, L. (2007) Cyclo-oxygenase-2 and its inhibition in cancer: is there a role? Drugs 67, 821-845
23. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., and Taketo, M. M. (1996) Suppression of intestinal polyposis in Apc delta 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803-809
24. Torrance, C. J., Jackson, P. E., Montgomery, E., Kinzler, K. W., Vogelstein, B., Wissner, A., Nunes, M., Frost, P., and Discafani, C. M. (2000) Combinatorial chemoprevention of intestinal neoplasia. Nat. Med. 6, 1024-1028
25. Ye, X., Hama, K., Contos, J. J., Anliker, B., Inoue, A., Skinner, M. K., Suzuki, H., Amano, T., Kennedy, G., Arai, H., Aoki, J., and Chun, J. (2005) LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature 435, 104-108
26. Shida, D., Kitayama, J., Yamaguchi, H., Yamashita, H., Mori, K., Watanabe, T., and Nagawa, H. (2005) Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells. World J. Gastroenterol. 11, 5638-5643
27. Fan, X. C., and Steitz, J. A. (1998) Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 17, 3448-3460
28. Eaton, E. M., and Sealy, L. (2003) Modification of CCAAT/ enhancer-binding protein-beta by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3. J. Biol. Chem. 278, 33416-33421
29. Descombes, P., and Schibler. U. (1991) . A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67, 569-579
30. Pontsler, A. V., St Hilaire, A., Marathe, G. K., Zimmerman, G. A., and McIntyre, T. M. (2002) Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein. J. Biol. Chem. 277, 13029-13036
31. Hahn, A., Barth, H., Kress, M., Mertens, P. R., and Goppelt-Struebe, M. (2002) Role of Rac and Cdc42 in lysophosphatidic acid-mediated cyclo-oxygenase-2 gene expression. Biochem. J. 362, 33-40
32. Smith, W. L., DeWitt, D. L., and Garavito, R. M. (2000) Cyclooxygenases: structural, cellular, and molecular biology Annu. Rev. Biochem. 69, 145-182
33. Chen, L. C., Chen, B. K., Chang, J. M., and Chang, W. C. (2004) Essential role of c-Jun induction and coactivator p300 in epidermal growth factor-induced gene expression of cyclooxygenase-2 in human epidermoid carcinoma A431 cells. Biochim. Biophys. Acta 1683, 38-48
34. Brown, P. H., Alani, R., Preis, L. H., Szabo, E., and Birrer, M. J. (1993) Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene 8, 877-886
35. Wang, D., You, Y., Lin, P. C., Xue, L., Morris, S. W., Zeng, H., Wen, R., and Lin, X. (2007) Bcl10 plays a critical role in NF-kappaB activation induced by G protein-coupled receptors. Proc. Natl. Acad. Sci. U. S. A. 104, 145-150
36. McAllister-Lucas, L. M., Ruland, J., Siu, K., Jin, X., Gu, S., Kim, D. S., Kuffa, P., Kohrt, D., Mak, T. W., Nunez, G., and Lucas, P. C. (2007) CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells. Proc. Natl. Acad. Sci. U. S. A. 104, 139-144
37. Sundfeldt, K., Ivarsson, K., Carlsson, M., Enerback, S., Janson, P. O., Brannstrom, M., and Hedin, L. (1999) The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBPbeta during epithelial tumour progression. Br. J. Cancer 79, 1240-1248
38. Cok, S. J., Acton, S. J., and Morrison. A. R. (2003) The proximal region of the 3′-untranslated region of cyclooxygenase-2 is recognized by a multimeric protein complex containing HuR, TIA-1, TIAR, and the heterogeneous nuclear ribonucleoprotein U. J. Biol. Chem. 278, 36157-36162
39. Lee, H. K., and Jeong, S. (2006) Beta-Catenin stabilizes cyclooxygenase-2 mRNA by interacting with AU-rich elements of 3′-UTR. Nucleic Acids Res. 34, 5705-5714
40. Dean, J. L., Sully, G., Clark, A. R., and Saklatvala, J. (2004) The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell Signal. 16, 1113-1121
41. Sengupta, S., Jang, B. C., Wu, M. T., Paik, J. H., Furneaux, H., and Hla, T. (2003) The RNA-binding protein HuR regulates the expression of cyclooxygenase-2. J. Biol. Chem. 278, 25227-25233
42. Ristimaki, A., Narko, K., and Hla, T. (1996) Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem. J. 318, 325-331
43. Denkert, C., Weichert, W., Pest, S., Koch, I., Licht, D., Kobel, M., Reles, A., Sehouli, J., Dietel, M., and Hauptmann, S. (2004) Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res. 64, 189-195
44. Ki, S. H., Choi, M. J., Lee, C. H., and Kim, S. G. (2007) Galpha12 specifically regulates COX-2 induction by sphingosine 1-phosphate. Role for JNK-dependent ubiquitination and degradation of IkappaBalpha. J. Biol. Chem. 282, 1938-1947
45. Nie, M., Pang, L., Inoue, H., and Knox, A. J. (2003) Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-1beta in human airway smooth muscle cells: involvement of different promoter elements, transcription factors, and histone h4 acetylation. Mol. Cell. Biol. 23, 9233-9244
46. Wu, K. K., Liou, J. Y., and Cieslik, K. (2005) Transcriptional control of COX-2 via C/EBPbeta. Arterioscler. Thromb. Vasc. Biol. 25, 679-685
47. Nakajima, T., Kinoshita, S., Sasagawa, T., Sasaki, K., Naruto, M., Kishimoto, T., and Akira, S. (1993) Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc. Natl. Acad. Sci. U. S. A. 90, 2207-2211
48. Cesena, T. I., Cardinaux, J. L., Kwok, R., and Schwartz, J. (2007) CCAAT/enhancer-binding protein (C/EBP) beta is acetylated at multiple lysines: acetylation of C/EBPbeta at lysine 39 modulates its ability to activate transcription. J. Biol. Chem. 282, 956-967
49. Kim, J., Cantwell, C. A., Johnson, P. F., Pfarr, C. M., and Williams, S. C. (2002) Transcriptional activity of CCAAT/ enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylation. J. Biol. Chem. 277, 38037-38044
50. Daub, H., Wallasch, C., Lankenau, A., Herrlich, A., and Ullrich, A. (1997) Signal characteristics of G protein-transactivated EGF receptor. EMBO J. 16, 7032-7044
51. Wu, J., and Cunnick, J. M. (2002) Trans-regulation of epidermal growth factor receptor by lysophosphatidic acid and G protein-coupled receptors. Biochim. Biophys. Acta 1582, 100-106
52. Rubio, I., Rennert, K., Wittig, U., and Wetzker, R. (2003) Ras activation in response to lysophosphatidic acid requires a permissive input from the epidermal growth factor receptor. Biochem. J. 376, 571-576
53. Normanno, N., De Luca, A., Bianco, C., Strizzi, L., Mancino, M., Maiello, MR., Carotenuto, A., De Feo, G., Caponigro, F., Salomon, D. S. (2006) Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366, 2-16
54. Schulte, K. M., Beyer, A., Kohrer, K., Oberhauser, S., and Roher, H. D. (2001) Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer. Int. J. Cancer 92, 249-256
55. Kitayama, J., Shida, D., Sako, A., Ishikawa, M., Hama, K., Aoki, J., Arai, H., and Nagawa, H. (2004) Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma. Breast Cancer Res. 6, R640-R646
56. Huang, M. C., Lee, H. Y., Yeh, C. C., Kong, Y., Zaloudek, C. J., and Goetzl. E. J. (2004) Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2). Oncogene 23, 122-129
57. Xu, J., Lai, Y. J., Lin, W. C., and Lin, F. T. (2004) TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor. J. Biol. Chem. 279, 10459-10468
58. Park, S. Y., Schinkmann, K. A., and Avraham, S. (2006) RAFTK/ Pyk2 mediates LPA-induced PC12 cell migration. Cell Signal. 18, 1063-1071
59. Zaslavsky, A., Singh, L. S., Tan, H., Ding, H., Liang, Z., and Xu, Y. (2006) Homo- and hetero-dimerization of LPA/S1P receptors, OGR1 and GPR4. Biochim. Biophys. Acta 1761, 1200-1212
60. Denkert, C., Koch, I., von Keyserlingk, N., Noske, A., Niesporek, S., Dietel, M., and Weichert, W. (2006) Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Mod. Pathol. 19, 1261-1269
61. Denkert, C., Weichert, W., Winzer, K. J., Muller, B. M., Noske, A., Niesporek, S., Kristiansen, G., Guski, H., Dietel, M., and Hauptmann, S. (2004) Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma. Clin. Cancer Res. 10, 5580-5586
62. Erkinheimo, T. L., Lassus, H., Sivula, A., Sengupta, S., Furneaux, H., Hla, T., Haglund, C., Butzow, R., and Ristimaki, A. (2003) Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. Cancer Res. 63, 7591-7594